Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Oct 19, 9:10 AMPacBio enters multi-year strategic collaboration with Verily to integrate HiFi long-read sequencing into Verily data and AI platform
Index
RUT
Market Cap
630.99M
Enterprise Value
1.10B
Income
-131.39M
Sales
159.27M
Book/sh
-0.11
Cash/sh
0.76
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
485
IPO
Oct 27, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
3.96
P/B
-
P/C
2.66
P/FCF
-
EV/EBITDA
-
EV/Sales
6.91
Quick Ratio
4.03
Current Ratio
4.92
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-0.43
EPS next Y
-0.45
EPS next Q
-0.13
EPS this Y
74.10%
EPS next Y
5.00%
EPS next 5Y
41.41%
EPS past 3/5Y
-9.18% -
Sales past 3/5Y
7.64% 15.19%
EPS Y/Y TTM
75.85%
Sales Y/Y TTM
2.02%
EPS Q/Q
-3.08%
Sales Q/Q
-1.91%
Insider Own
8.56%
Insider Trans
-2.52%
Inst Own
53.88%
Inst Trans
1.16%
ROA
-16.66%
ROE
-929.32%
ROIC
-19.56%
Gross Margin
34.29%
Oper. Margin
-101.67%
Profit Margin
-82.49%
SMA20
-5.01%
SMA50
23.08%
SMA200
27.12%
Trades
Shs Outstand
310.81M
Shs Float
284.22M
52W High
3.43 -40.90%
52W Low
1.07 89.72%
Volatility
10.74% 13.83%
ATR (14)
0.24
RSI (14)
52.95
Beta
2.24
Rel Volume
0.05
Avg Volume
10.92M
Volume
26,979
Perf Week
2.01%
Perf Month
38.10%
Perf Quarter
45.00%
Perf Half Y
18.71%
Perf YTD
8.56%
Perf Year
6.84%
Perf 3Y
-72.53%
Perf 5Y
-92.06%
Perf 10Y
-77.47%
Prev Close
1.96
Price
2.03
Change %
3.57%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibson James R IISee RemarksOct 06 '26Option Exercise1.18500,000590,0001,745,663Oct 08 04:07 PM
Gibson James R IISee RemarksOct 06 '26Sale3.11661,8152,056,9211,083,848Oct 08 04:07 PM
Jim GibsonOfficerOct 06 '26Proposed Sale2.87661,8151,899,409Oct 06 04:23 PM
Van Oene MarkSee RemarksAug 17 '26Sale1.1326,91130,4092,705,853Aug 18 08:17 PM
MARK VAN OENEOfficerAug 17 '26Proposed Sale1.1326,91130,512Aug 17 04:08 PM
Gibson James R IISee RemarksApr 01 '26Sale1.3788,185120,8131,245,663Apr 03 04:05 PM
JAMES GIBSONOfficerApr 01 '26Proposed Sale1.3788,185120,778Apr 01 05:17 PM
HENRY CHRISTIAN OSee RemarksMar 03 '26Sale1.5112,49718,9203,581,813Mar 04 05:55 PM
Van Oene MarkSee RemarksMar 03 '26Sale1.516,5049,8472,243,634Mar 04 05:54 PM
Farmer MicheleSee RemarksMar 03 '26Sale1.512,9794,510305,948Mar 04 05:54 PM
MARK D. VAN OENEOfficerMar 03 '26Proposed Sale1.516,5049,849Mar 03 04:24 PM
CHRISTIAN HENRYOfficerMar 03 '26Proposed Sale1.5112,49718,924Mar 03 04:20 PM
Van Oene MarkSee RemarksFeb 17 '26Sale1.58129,790204,5491,797,745Feb 19 08:33 PM
Van Oene MarkSee RemarksFeb 18 '26Sale1.6355,10789,7691,742,638Feb 19 08:33 PM
HENRY CHRISTIAN OSee RemarksFeb 17 '26Sale1.58331,793522,9062,814,374Feb 19 08:31 PM
HENRY CHRISTIAN OSee RemarksFeb 18 '26Sale1.63140,874229,4842,673,500Feb 19 08:31 PM
Farmer MicheleSee RemarksFeb 17 '26Sale1.5835,21555,499234,044Feb 19 08:28 PM
Farmer MicheleSee RemarksFeb 18 '26Sale1.6314,95224,357219,092Feb 19 08:28 PM
MARK VAN OENEOfficerFeb 17 '26Proposed Sale1.58303,739478,693Feb 17 06:27 PM
CHRISTIAN HENRYOfficerFeb 17 '26Proposed Sale1.58606,312955,548Feb 17 06:25 PM
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
CEOMr. Mark Van Oene Ph.D.
CFO & Principal Accounting OfficerMr. James R. Gibson II
Senior Business Advisor & DirectorMr. Christian O. Henry M.B.A.
Co-FounderDr. Stephen Turner Ph.D.
Ph.D.Dr. Brett Atkins J.D.